vimarsana.com

Page 11 - நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UAE approves China s Sinopharm vaccine, says it has 86% efficacy against coronavirus -- Society s Child -- Sott net

© Reuters / Khushnum Bhandari People wait for vaccine trials at Abu Dhabi National Exhibition Center in Abu Dhabi, United Arab Emirates, October 6, 2020 The Health Ministry of the United Arab Emirates has registered an experimental coronavirus vaccine produced by China National Pharmaceutical Group (Sinopharm), after late-stage clinical trials showed it had 86 percent efficacy. The Ministry of Health and Prevention (MOHAP) said Wednesday the authorities had considered the application from Sinopharm, and the registration of the vaccine was a significant vote of confidence in its safety and efficacy. MOHAP and Department of Health Abu Dhabi had reviewed Sinopharm s interim analysis of the phase-three trials, saying it shows Beijing Institute of Biological Products inactivated vaccine has 86 percent efficacy against Covid-19 infection.

MEED | Mena nations ramp up Covid-19 vaccine plans

Recoveries: 350,347 Actions to slow the spread of Covid-19: 10 December: Saudi Food and Drug Authority (SFDA) says it has approved the registration of Pfizer-BioNTech s Covid-19 vaccine in the kingdom. The approval was based on the data provided by Pfizer on 24 November. 7 December: The first group of Umrah performers from outside the country have arrived in Madina, including 135 visitors from Indonesia. The visitors have been quarantined for three days and their entry will be managed using the Eatmarna Umrah mobile app. 6 December: The Assistant Minister of Health and official spokesman of the Saudi Ministry of Health Muhammad al-Abdulaali has stated that Saudi Arabia has signed very important contracts with companies developing the coronavirus vaccine , adding that the registration mechanism for taking the vaccine will be announced soon.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.